drugset / Trial / NCT00143156

Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

NCT00143156

Phase 3 Completed 450 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of pregabalin administered twice a day compared to placebo in reducing pain in subjects with painful diabetic peripheral neuropathy.

Timeline

Start
2005-03
Primary completion
Completion
2007-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications